Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Segments
  2. Solutions
  3. Insights
  4. Events
  5. About
  6. Contact Us
MAIN/search
MAIN/Segments
Segments/
Segments
  • Pharmaceutical
  • Consumer Health
  • MedTech
  • Public Health & Government
  • Payer & Provider
Pharmaceutical (Global page)

Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.

Learn More
Consumer Health

Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.

LEARN MORE
MedTech

Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.

Learn more
Public Health & Government

Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.

LEARN MORE
Payer & Provider

Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.

learn more
Healthcare Provider Solutions
MAIN/Solutions
Solutions/
Solutions
  • Research & Development
  • Real World Evidence
  • Information Insights
  • Market Research
  • Strategy Consulting
  • Contract Sales & Medical Solutions
  • Patient Solutions
  • AI, Digital & Technology Solutions
Research & Development (Global page)

Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.

Learn More
Real World Evidence

Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.

LEARN MORE
Information Insights

Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.

LEARN MORE
Market Research

Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.

LEARN MORE
Strategy Consulting

Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.

LEARN MORE
Related Solutions
Contract Sales & Medical Solutions (Global page)

Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.

LEARN MORE
Patient Solutions (Global page)

A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.

LEARN MORE
AI, Digital & Technology Solutions

Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.

LEARN MORE
MAIN/Insights
Insights/
Our Latest Whitepapers

Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific. 

Learn More
Blogs, Case Studies & Podcasts

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

Discover Insights

IQVIA APAC Insight

"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.

Read The Latest Issue
MAIN/Events
Events/
Upcoming Events & Webinars

View our upcoming events and webinars.

Explore The Latest
On-Demand Webinars

Visit our library of on-demand webinars.

Discover Insights

Featured Event

"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers

Learn More
MAIN/About
About/
Newsroom

Read the latest updates and press releases.

Learn More
Career Opportunities

Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search Jobs

APAC FOOTPRINT

"Explore our Asia Pacific locations.

Learn more
MAIN/Contact Us
Contact Us/
Livre Blanc
Economic Burden of Respiratory Syncytial Virus (RSV) Infection Among Older Adults in Select Asia-Pacific Economic Cooperation (APEC) Countries
Nov 27, 2024
  • Locations
  • Asia Pacific
  • Economic Burden of Respiratory Syncytial Virus (RSV) Infection Among Older Adults in Select Asia-Pacific Economic Cooperation (APEC) Countries

Get instant access

Download

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory pathogen causing severe lower respiratory tract diseases, particularly in older adults (age ≥60 years). Annually, RSV accounts for around 5.2 million cases and 33,000 in-hospital deaths among older adults in high-income countries. Factors like immune decline, lung aging, and comorbidities increase susceptibility.

The economic impact of RSV on healthcare systems in high-income Asia-Pacific Economic Cooperation (APEC) countries (China, Japan, South Korea, Canada, Singapore, New Zealand, Australia, Hong Kong, Taiwan) is significant but challenging to quantify due to insufficient epidemiological and healthcare resource data for older adults. Routine RSV testing is uncommon due to non-specific symptoms overlapping with other infections. Diagnosis often relies on local epidemiology rather than lab tests, leading to inconsistent testing methods.

Our study estimated the clinical and economic burden of RSV among older adults in high-income APEC countries. A literature review identified evidence on the incidence and costs associated with RSV hospitalizations. In 2023, RSV caused approximately 778,000 hospitalizations and USD 2.8 billion in costs. The highest estimated burden was seen in China, followed by Japan and Canada. On average, 1 in 500 older adults were hospitalized annually, with hospitalization costs ranging from USD 2,735 in New Zealand to USD 12,826 in Canada.

Therefore, there is a need for an urgent strategic mitigation plan to address the growing burden of RSV infection. Our study's data will guide future prevention programs and be crucial for regulatory decision-making and healthcare planning. These measures will help ease the RSV burden on healthcare systems and economies. Read the full white paper for more insights.

Contact Us